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Abstract Type 2 diabetes mellitus (T2DM) is characterized
by obesity, hyperglycemia and insulin resistance. Both T2DM
and obesity are associated with cerebral complications, in-
cluding an increased risk of cognitive impairment and demen-
tia, however the underlyingmechanisms are largely unknown.
In the current study, we aimed to determine the relative con-
tributions of obesity and the presence of T2DM to altered
white matter structure. We used diffusion tensor imaging
(DTI) and voxel-based morphometry (VBM) to measure
white matter integrity and volume in obese T2DM patients
without micro- or macrovascular complications, age- gender-
and BMI-matched normoglycemic obese subjects and age-
and gender-matched normoglycemic lean subjects. We found
that obese T2DM patients compared with lean subjects had
lower axial diffusivity (in the right corticospinal tract, right
inferior fronto-occipital tract, right superior longitudinal fas-
ciculus and right forceps major) and reduced white matter
volume (in the right inferior parietal lobe and the left external
capsule region). In normoglycemic obese compared with lean
subjects axial diffusivity as well as white matter volume
tended to be reduced, whereas there were no significant dif-
ferences between normoglycemic obese subjects and T2DM
patients. Decreased white matter integrity and volume were
univariately related to higher age, being male, higher BMI,
HbA1C and fasting glucose and insulin levels. However, mul-
tivariate analyses demonstrated that only BMI was indepen-
dently related to white matter integrity, and age, gender and
BMI to white matter volume loss. Our data indicate that obese
T2DM patients have reduced white matter integrity and vol-
ume, but that this is largely explained by BMI, rather than
T2DM per se.
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Introduction
Obesity and type 2 diabetes mellitus (T2DM) are major public
health problems, not only due to their pandemic occurrence,
but also due to their association with adverse consequences,
such as cardiovascular disease, cancer and cerebral complica-
tions (Kullmann et al. 2015; Geijselaers et al. 2015). T2DM is
characterized by hyperglycemia and obesity-related insulin
resistance (Kahn 2003; Kahn et al. 2006). Patients with
T2DM are at an increased risk of (vascular) dementia (Crane
et al. 2013), stroke (Aoki and Uchino 2011), white matter
lesions (Roriz-Filho et al. 2009) and cognitive impairment
(Benedict et al. 2012; Reijmer et al. 2010). Furthermore,
T2DM is related to loss of grey and white matter volume
(Moran et al. 2013) and to loss of white matter integrity
(Reijmer et al. 2010). Although less well established, obesity
is also associated with brain disease, including an increased
risk of dementia and accelerated cognitive decline at older
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age, with complementary structural brain changes (Gustafson
et al. 2003; Gunstad et al. 2007; Kullmann et al. 2015). Both
obesity-related insulin resistance and hyperglycemia seem
strong risk factors for cerebral pathology (Rusinek and
Convit 2014).
Studies assessing brain alterations in T2DM usually in-
clude a heterogeneous sample of patients in early and more
advanced stages of the disease, i.e., with clinically manifest
microvascular and cardiovascular complications. It is there-
fore not yet clear to what extent structural brain changes are
present in early stages of T2DM. Imaging studies in obese
subjects have likewise included heterogeneous or inadequate-
ly characterized samples with regard to glucose tolerance, in-
sulin resistance, and sometimes cardiovascular disease
(Rusinek and Convit 2014).
In the current study, we aimed to determine the relative
contributions of obesity and the presence of non-
complicated T2DM to altered white matter volume and integ-
rity. We therefore performed voxel-based morphometry
(VBM) and diffusion tensor imaging (DTI) in obese T2DM
patients, BMI-matched normoglycemic obese subjects and
normoglycemic lean subjects. We hypothesized that white
matter integrity and volume are altered in obese T2DM
patients compared with BMI-matched normoglycemic obese
subjects and lean subjects.
Methods
Participants
This study, part of a larger study (NCT01281228), was ap-
proved by the Medical Ethics Committee of the VU
University Medical Center and was performed in accordance
with the Helsinki Declaration. All participants provided writ-
ten informed consent before participation. We included 16
obese T2DM patients, 16 obese normoglycemic and 16
healthy lean individuals. Inclusion and exclusion criteria have
been reported previously (van Bloemendaal et al. 2014).
Briefly, inclusion criteria included right-handedness, BMI
>30 kg/m2 for obese individuals and T2DM patients, BMI
<25 kg/m2 for lean controls, normoglycemia for obese indi-
viduals and lean controls as defined by fasting plasma glucose
<5.6 mmol/l and 2-h glucose <7.8 mmol/l following a 75 g
oral glucose tolerance test (OGTT). For T2DM patients,
HbA1c had to be 6.0–8.5 %. Exclusion criteria included car-
diovascular diseases, micro-albuminuria, neurological or psy-
chiatric disorders including depression (assessed by Center for
Epidemiologic Studies Depression scale) (Schroevers et al.
2000), substance abuse or use of any centrally acting agent.
Microalbuminuria was tested by calculating the albumin: cre-
atinine ratio in urine, and was defined as an albumin:creatinine
ratio >2.5 for men or >3.5 for women.
Data acquisition
MRI scanning was performed on a 3.0 Tesla GE Signa HDxt
scanner (General Electric, Milwaukee, Wisconsin, USA)
using an 8-channel phased-array head coil. For this study we
used an echo planar imaging based DTI acquisition consisting
of 5 volumes without directional weighting and 30 volumes
with 30 non-collinear diffusion gradient directions (b-value
1000 s/mm2, repetition time (TR) 6200 ms, echo time (TE)
81 ms, 45 contiguous axial slices of 2.4 mm). Participants
furthermore had a T2-based Fluid Attenuating Inverse
Recovery (3D-FLAIR; TR 8000 ms, TE 126 ms, slice thick-
ness 1.2 mm) and a T1-weighted fast spoiled gradient-echo
(TR 8.2 ms, TE 3.2 ms, 1 mm slice thickness) sequence.
DTI tract-based analysis
Processing of DTI-scans was performed using the FMRIB’s
Diffusion Toolbox of FMRI’s Software Library (FSL) version
5.04 (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki) (Smith et al. 2004).
First, DTI scans and gradient-vectors were corrected for mo-
tion and eddy-current induced distortions (Leemans and Jones
2009). Next, the diffusion tensor was calculated for each vox-
el, providing fractional anisotropy (FA), axial (λ1), radial
(mean of λ2 and λ3) and mean diffusivity (mean of λ1, λ2
and λ3) (Pierpaoli and Basser 1996; Basser and Jones 2002).
Tract-based spatial statistics (TBSS) was used for voxelwise
statistical analysis, which does not use spatial smoothing
(Smith et al. 2006). All individual FA images were non-
linearly registered to FMRIB58FA standard space, to allow
group averaging and comparison. These registered images
were then averaged and the mean image was skeletonized,
and thresholded at 0.2 to include only white matter.
Individual non-linear warps and skeleton projection of
FA-images were used to project axial, radial and mean
diffusivity to the skeleton and to allow voxelwise statistics.
All steps were manually checked, no errors occurred.
VBM analysis
T1-weighted images were visually inspected for motion arte-
facts. Data preprocessing was performed with Statistical
Parametric Mapping 8 software (SPM8; Wellcome Trust
Center for Neuroimaging, London, UK; http://www.fil.ion.
ucl.ac.uk/spm). First, structural images were oriented along
the anterior/posterior commissure axis and segmented into
grey matter, white matter and cerebrospinal fluid with a bias-
field correction cut-off of 60 mm full width at half maximum
(FWHM). In the next step, DARTEL (Diffeomorphic
Anatomical Registration Through Exponentiated Lie
Algebra) was used to create a group-specific grey and white
matter template and the individual flow fields. These flow
fields contain the non-linear deformations between each
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individual’s MRI-scan and the DARTEL template. The indi-
vidual grey and white matter segmentations were registered to
MNI standard space using linear affine registration and non-
linear deformation using the flow fields. The images were
modulated to preserve relative volume and corrected for brain
size, in order to allow group comparisons. Lastly, the segment-
ed, modulated and normalized images were smoothed using
an 8 mm FWHM Gaussian kernel. Both segmentation and
normalization results were manually checked, no errors
occurred.
White matter lesions
White matter lesions were scored visually by an experienced
neuro-radiologist (FB) based on 3D-FLAIR sequence using
Fazekas criteria (Fazekas et al. 1987).
Statistical analyses
Clinical group data are expressed as mean ±SEM (unless
otherwise stated) and were analyzed with the Statistical
Package for the Social Sciences (SPSS) version 20 (SPSS,
Chicago, IL, USA). Between group differences in clinical da-
ta, including white matter lesions, were analyzed using a one-
way ANOVA with Bonferroni post-hoc correction or χ2-test
whether appropriate.
Differences in DTI parameters between groups were ana-
lyzed with the FSL function Brandomise^, using threshold-
free cluster enhancement non-parametric permutation testing
(5000 permutations). This method does not require a mini-
mum cluster size to be defined a priori. Family Wise Error
(FWE) was applied as multiple comparisons correction. For
the VBM analysis of white matter volume, clusters were con-
sidered relevant if at least 150 voxels at Puncorrected < 0.002.
Those clusters were subsequently whole brain cluster-wise
corrected for multiple comparisons using FWE. This mini-
mum of 150 voxels ensured that only larger, more relevant
alteration patterns were found, reducing the risk of false-
positive findings and increasing the reliability of the results.
Both the DTI and VBM analyses were corrected for age,
gender and systolic blood pressure. A P-value <0.05 after
FWE-correction was considered statistically significant.
Using FSL the mean value of white matter integrity of
voxels differing between groups was extracted. For each sub-
ject the mean white matter volume of significant clusters was
extracted using MarsBar 0.41 (http://marsbar.sourceforge.
net). Using Spearman’s ρ the demographical and clinical
correlates of altered volume/integrity were determined.
These correlations were calculated in all participants. To
determine the strongest predictors, variables significantly




Due to technical problems, DTI scans were not available for 1
lean control and 1 obese subject. All subjects were matched
for age and gender, while T2DM patients and normoglycemic
obese subjects were also BMImatched (Table 1). Patients with
T2DM had higher systolic blood pressure, HbA1c, fasting
plasma glucose and insulin levels compared with
normoglycemic obese and lean subjects. Total cholesterol
and LDL cholesterol levels were lower in T2DM patients
compared with obese and lean subjects, whereas HDL choles-
terol levels were higher in lean compared with T2DM and
obese subjects. Eight T2DM patients were treated with met-
formin monotherapy and 8 used metformin in combination
with a sulfonylurea. Twelve T2DM patients and 3 obese sub-
jects used antihypertensivemedication, 13 T2DMpatients and
1 obese subject used statins. There were no significant differ-
ences in Fazekas score (white matter lesions) between the
groups (P=0.8) (Table 1).
White matter integrity
DTI tract-based analyses showed significantly lower axial dif-
fusivity (λ1) in T2DM patients compared with lean subjects.
Tracts most affected were the right corticospinal tract, right
inferior fronto-occipital tract, right superior longitudinal fas-
ciculus and right forceps major (Fig. 1a). On the left side of the
forceps major there was a cluster of voxels where axial diffu-
sivity tended to be lower in subjects with obesity compared
with lean controls (PFWE=0.1; Fig. 1b). There were no signif-
icant differences in FA, mean diffusivity and radial diffusivity
between T2DM patients, normoglycemic obese and lean
subjects.
White matter volume
VBM analyses demonstrated significantly lower white matter
volume in T2DM patients relative to lean control subjects in a
left hemisphere cluster comprising predominantly the external
capsule region. Another cluster of lower white matter volume
in T2DM patients versus lean control subjects was found in
the right inferior parietal lobe (Fig. 2a; Table 2).
In normoglycemic obese comparedwith lean subjects, low-
er white matter volume was found in the left external capsule
region as well (Fig. 2b; Table 2), although this cluster was
smaller than the cluster found in T2DM patients. In addition,
this cluster was not statistically significant after FWE-
correction for multiple comparisons (PFWE=0.380). No dif-
ferences were identified in the comparison between
normoglycemic obese subjects and T2DM patients.
Metab Brain Dis (2016) 31:621–629 623
Associations between white matter parameters
and biomedical variables
For each subject the mean axial diffusivity value was extracted
for the significant voxels in the comparison between T2DM
patients and lean controls. The same was done for white mat-
ter volume of the two VBM clusters that reached statistical
significance when comparing T2DM patients with lean con-
trol subjects. With these values correlations with demographic
and clinical characteristics were calculated in the overall
group. As can be found in Table 3, univariate correlations of
lower axial diffusivity with higher BMI, fasting plasma glu-
cose, fasting insulin levels and HbA1c were significant. Of
these variables, higher BMI was the only independent predic-
tor of lower axial diffusivity (β=−0.48; P=0.001), which
explained 21 % of the variance. Lower white matter volume
in the left external capsule cluster was univariately related to
higher age, BMI, fasting plasma glucose and insulin levels,
HbA1c, and being male. Being male (β=0.432; P<0.001),
higher BMI (β = −0.353; P = 0.002) and higher age
(β=−0.342;P=0.003) were independently related with lower
white matter volume in this cluster. This model explained
47 % of the variance of white matter volume differences in
this cluster. Similar univariate correlations were found for the
cluster of lower white matter volume in the right inferior pa-
rietal lobe, with the exception of fasting plasma glucose
(Table 2). Independent predictors were gender (being male;
β=0.449; P<0.001), higher age (β=−0.345; P=0.004), and
higher BMI (β=−0.284; P=0.016), together explaining 44%
of the variance.
Discussion
In the current study we showed that both white matter
integrity, as measured by axial diffusivity, and white
matter volume are decreased in obese T2DM patients
compared with lean subjects. In normoglycemic obese
compared with lean subjects axial diffusivity as well as
white matter volume tended to be reduced, whereas there
were no significant differences between normoglycemic
obese subjects and T2DM patients. Higher BMI indepen-
dently predicted decreased white matter integrity, and,
together with higher age and being male, it predicted
lower white matter volume as well. Higher HbA1C,
fasting plasma glucose and insulin levels were no inde-
pendent predictors of decreased white matter volume and
integrity.
Table 1 Subject characteristics
Lean (n= 15) Obese (n= 15) T2DM (n = 16) ANOVA P-value
Age (years) 57.3 ± 1.9 57.7 ± 2.2 61.4 ± 1.5 0.2
Gender, male/female (n) 8/7 8/7 8/8 –
Weight (kg) 71.5 ± 2.9 100.7 ± 3.0* 97.9 ± 3.0* <0.001
Body mass index (kg/m2) 23.4 ± 0.4 32.6 ± 0.8* 34.0 ± 0.9* <0.001
Waist circumference (cm) 85.7 ± 2.1 112.3 ± 2.2* 115.7 ± 1.8* <0.001
Systolic blood pressure (mmHg) 119± 4 127 ± 3 141 ± 3† <0.001
Diastolic blood pressure (mmHg) 76 ± 2 79± 2 83± 2 0.057
Fasting plasma glucose (mmol/l) 5.2 ± 0.1 5.3 ± 0.1 8.4 ± 0.5† <0.001
Glucose 2 h after OGTT (mmol/l) 5.1 ± 0.3 5.4 ± 0.2 – 0.4
HbA1c (%) 5.5 ± 0.03 5.5 ± 0.06 6.9 ± 0.22† <0.001
HbA1c (mmol/mol) 37 ± 0.3 37± 0.7 52± 2.4† <0.001
Total cholesterol (mmol/l) 5.6 ± 0.2 5.6 ± 0.2 4.5 ± 0.3† 0.002
LDL-cholesterol (mmol/l) 3.3 ± 0.2 3.4 ± 0.2 2.3 ± 0.2† <0.001
HDL-cholesterol (mmol/l) 1.9 ± 0.1 1.4 ± 0.1* 1.3 ± 0.1* <0.001
Triglycerids (mmol/l) 0.9 ± 0.1 1.7 ± 0.3 1.8 ± 0.3 0.046
Fasting NEFA (mmol/l) 0.46 ± 0.04 0.45± 0.03 0.64± 0.04† 0.001
Fasting insulin (pmol/l) 36 ± 2.8 81± 14 117 ± 17† <0.001
Diabetes duration (years) – – 7.0 [4.25, 10.75] –
Fazekas score (0; 1; 2; 3) 6; 7; 2; 0 8; 5; 2; 0 5; 9; 2; 0 0.8
Data are means ± SEM or median [interquartile range]
Fazekas score for white matter lesions: 0 indicates no lesions; 1 indicates punctate foci; 2 indicates beginning
confluence of foci; 3 indicates large confluent areas
OGTT oral glucose tolerance test, NEFA non-esterified fatty acids, T2DM type 2 diabetes patients
*Statistically significant different from lean (post-hoc Bonferroni corrected P< 0.05)
†Statistically significant different from lean and obese (post-hoc Bonferroni corrected P< 0.05)
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Using DTI, we found that obese T2DM patients compared
with lean subjects have lower axial diffusivity in the right
corticospinal tract, right inferior fronto-occipital tract, right
superior longitudinal fasciculus and right forceps major. Our
findings are in line with previous studies showing lower axial
diffusivity in type 1 diabetes patients with and without micro-
vascular complications in comparable tracts (van Duinkerken
et al. 2012) and in T2DM patients (Hoogenboom et al. 2014),
Fig. 1 Changes in axial diffusivity in T2DM patients and obese
compared with lean subjects. a Brain slices showing decreased axial
diffusivity (λ1) in T2DM patients compared with lean subjects in right
corticospinal tract, right inferior fronto-occipital tract, right superior
longitudinal fasciculus and right forceps major; b Brain slices showing
a cluster of voxels on the left side of the forceps major where axial
diffusivity tended to be lower in subjects with obesity compared with
controls (PFWE = 0.11). The mean skeleton is shown in green, and
significant differences are displayed as thickened tracts in blue for
visualization purposes. Left side of the axial slices is the right side of
the brain. X, y, z are the Montreal Neurological Institute (MNI)
coordinates of the brain in standard space
Fig. 2 Reduced white matter volume in T2DM patients compared with
lean subjects. a Brain slices showing clusters of reduced white matter
volume in the external capsule region in obese T2DM patients
compared with lean subjects, as determined with VBM; b Brain slices
showing a cluster of reduced white matter volume in the external capsule
region in obese compared with lean subjects. This cluster, however, was
not statistically significant after FWE-correction for multiple
comparisons (PFWE = 0.380). The color scale reflects the T-value. Right
side of the axial slices is the right side of the brain. X, y, z are theMontreal
Neurological Institute (MNI) coordinates of the brain in standard space
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although the latter study only observed a trendwise reduced
axial diffusivity in the cingulum bundle. In the current study,
we combined DTI with VBM of white matter and found that
T2DM patients have reduced white matter volume in the right
inferior parietal lobe and the left external capsule region. A
previous study in a large cohort of T2DM patients (of which
24 % had known cardiovascular and 11 % cerebrovascular
complications), also demonstrated white matter loss in
T2DM, but mainly in frontal and temporal regions (Moran
et al. 2013). In addition, in obese adolescents with T2DM
versus BMI-matched non-diabetic subjects, reduced frontal
and whole brain white matter volume has been demonstrated,
paralleled by reductions in cognitive performance (Yau et al.
2010).
To determine the relative contributions of obesity and
T2DM to structural brain changes, we also studied
normoglycemic obese subjects (BMI-matched with the
T2DM patients). We found in normoglycemic obese com-
pared with lean subjects reduced axial diffusivity, as well as
reduced white matter volume, but these differences in white
matter integrity and volume were only trendwise significant
after strict FWE-correction for multiple comparisons. It could
be speculated that obesity is associated with early white matter
alterations and that hyperglycemia may further impact brain











T2DM<Lean External capsule L 5735 19.36 5.64 <0.001 <0.001 −32,9,2
4.99 <0.001 <0.001 −27,8,−13
4.03 <0.001 <0.001 17,−16,33
Inferior Parietal
Lobe
R 3276 11.06 4.69 <0.001 <0.001 45,−42,54
4.49 <0.001 <0.001 47,−31,30
4.48 <0.001 <0.001 39,−12,36
Obese < Lean External capsule L 903 3.05 4.62 <0.001 0.380 −32,5,−1
Axial diffusivity





R 1803 1.80 5.49 NA <0.05 22,−28,46
T t-statistic,P-FWE p-value Family-Wise Error corrected for multiple comparisons,R right, L left,MNIMontreal Neurological Institute coordinates in mm
NA not applicable
Table 3 Associations between
white matter parameters and
demographic and clinical
characteristics
Axial diffusivitya White matter volume cluster
Lb
White matter volume cluster
Rb
Spearman’s rho P-value Spearman’s rho P-value Spearman’s rho P-value
Age −0.09 0.573 −0.34 0.021 −0.30 0.041
Gender 0.27 0.069 0.52 <0.001 0.54 <0.001
BMI −0.47 0.001 −0.55 <0.001 −0.43 0.003
Fasting glucose −0.45 0.002 −0.31 0.035 −0.24 0.10
Fasting insulin −0.44 0.002 −0.40 0.006 −0.30 0.040
HbA1c −0.38 0.008 −0.42 0.004 −0.38 0.010
HDL 0.27 0.07 0.17 0.3 0.15 0.35
aMean axial diffusivity value for the significant voxels in the comparison between T2DM patients and lean
controls
bMean white matter volume of the two significant VBM clusters in the comparison between T2DM patients and
lean controls. With these values correlations with biomedical variables were calculated in all subjects (lean, obese
and T2DM)
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white matter structure. However, in the current study we found
no significant differences between obese T2DM patients and
obese normoglycemic subjects in white matter structure.
Relating our findings of localized lower white matter vol-
ume and integrity to specific functions is not straightforward
given the complexity of brain networks. However, it is well
known that the corticospinal tracts have a major role in motor
coordination, whereas the forceps major and parietal cortices
have been related to the transfer and processing of somatosen-
sory information. In a previous study in T2DM patients white
matter integrity of the inferior longitudinal fasciculus has been
related to cognitive functioning, mainly information process-
ing speed (Reijmer et al. 2013). Similar correlations between
the inferior fronto-occipital tract and cognition were found in
type 1 diabetes patients (van Duinkerken et al. 2012). Our
finding of reduced white matter volume in the external capsule
region in obese T2DM patients furthermore corroborates pre-
vious findings of white matter alterations in the external cap-
sule in obese versus lean women (Shott et al. 2015). The
external capsule connects medial and ventral prefrontal corti-
ces with limbic regions, contains fibers from both the inferior
fronto-occipital fasciculus and uncinate fasciculus, and con-
nects the hippocampus and amygdala with prefrontal and
OFC regions (Shott et al. 2015; Schmahmann et al. 2008).
Future studies are needed to better understand the conse-
quences of the observed changes in white matter volume and
integrity in our study.
We did not observe any differences in FA or any of the
other diffusion tensor parameters. Previous studies have
shown alterations in FA or mean and radial diffusivity in
T2DM (Hoogenboom et al. 2014; Hsu et al. 2010; Reijmer
et al. 2013). In the current study we only observed reduced
axial diffusivity in T2DM patients. The biological substrate of
axial diffusivity has mainly been derived from animal studies,
and therefore careful interpretation is required. These animal
studies, however, suggest that changes in axial diffusivity may
represent changes in integrity of axons (Madden et al. 2009;
Wheeler-Kingshott and Cercignani 2009). This could result
from a less favorable alignment of fibers within the bundle,
but it could also represent damage to the axons themselves. In
a mouse model of multiple sclerosis it was demonstrated that
greater decreases in axial diffusivity were associated with
greater amounts of axonal damage and withmore neurological
disability (Budde et al. 2008). Further studies are needed to
determine the clinical relevance of loss of axial diffusivity in
T2DM patients.
Results from the white matter volume analysis appear to be
more robust and extensive than those of the white matter in-
tegrity analysis. This may seem counterintuitive as white mat-
ter integrity is considered to be more sensitive to early alter-
ations than white matter volume. The difference, in this case,
may be due to our statistical approach. For the white matter
volume analysis, first clusters with a P<0.002 and aminimum
size of 150 voxels were identified. Those clusters were subse-
quently whole brain cluster-wise corrected for multiple com-
parisons using FWE. For the white matter integrity analysis
this approach is not available and a whole-brain voxel-wise
FWE-correction was used. Obviously, the latter approach is
more stringent and will yield less statistically significant
voxels. We chose the cluster-wise approach for the volumetric
analysis given the small sample size. These different ap-
proaches need to be taken into account when comparing both
results.
In the overall group we found univariate correlations be-
tween altered white matter integrity and volume, age, being
male, BMI, and fasting glucose and insulin levels. These cor-
relations suggest that hyperglycemia and insulin-resistance
partly relate to obesity/T2DM related cerebral alterations.
However, in a multivariate model only BMI was related to
white matter integrity, and age, gender and BMI to white mat-
ter volume loss. The association between higher BMI and
lower white matter volume is in line with a previous study
in elderly subjects (Raji et al. 2010). Obesity is characterized
by a chronic proinflammatory state (Johnson et al. 2012) and
low-grade inflammatory markers have been shown to be re-
lated to white matter integrity and other brain parameters
(Verstynen et al. 2013; Frodl and Amico 2014). In this study
no peripheral or central proinflammatory markers were
available, but future research should investigate this issue.
We also determined correlations between white matter
integrity/volume and HDL and LDL cholesterol. In the overall
group, the mean value of the cluster of lower axial diffusivity,
but not white matter volume, tended to correlate positively
with both cholesterol types. While the association with HDL
cholesterol is as anticipated, the direction of the correlation
with LDL seems counterintuitive (higher LDL correlates with
higher axial diffusivity values). This finding may however be
explained by the statin use in the obese and T2DM group,
which lowers LDL cholesterol levels. Therefore, this correla-
tion is likely to be unreliable in our current study design.
Ideally, such a correlation should be calculated in individuals
not using statins, which was not feasible in the current study
due to power issues. We have therefore excluded LDL from
the analyses.
For exploratory purposes we have added, besides BMI, oth-
er biomedical variables, such as fasting insulin and glucose, to
a second level statistical design to test whether regional white
matter integrity/volume is related to these variables. However,
given the study design, focusing on groups differing with re-
gard to T2DM and BMI, these tests will not be fully indepen-
dent of BMI. This is a different approach than the approach we
took by correlating clusters of altered integrity/volume to bio-
medical variables as a post-hoc analysis. This second level
whole brain statistical analysis did not show any statistically
significant correlations between white matter integrity/volume
and fasting plasma glucose or fasting plasma insulin.
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A strength of this study is that groups were well-
phenotyped as we only included patients with non-
complicated T2DM, BMI-matched normoglycemic subjects
and healthy lean subjects. A limitation of our study is the
relatively small sample size, limiting the power to detect sig-
nificant differences between the groups. However, despite the
small sample size we observed significant differences between
T2DM patients and lean subjects in measures of white matter
tract integrity and white matter volume. Another limitation of
the current study is that measurements of cognitive functions
were not performed. Previous studies have demonstrated as-
sociations between reduced white matter volume/integrity and
cognitive functions in T2DM as well as in obesity
(Hoogenboom et al. 2014; Moran et al. 2013; Reijmer et al.
2013; Zhang et al. 2014; Kullmann et al. 2015). Reduced
white matter integrity and volume may play a key role in
obesity- and T2DM-related cognitive impairment (Kullmann
et al. 2015).
In conclusion, we found that both white matter integrity
and white matter volume are focally decreased in obese pa-
tients with non-complicated T2DM compared with lean sub-
jects. In normoglycemic obese compared with lean subjects
axial diffusivity as well as white matter volume only tended to
be reduced. Higher BMI was an independent predictor of de-
creased white matter integrity as well as white matter volume.
Our data indicate that obese T2DM patients have reduced
white matter integrity and volume, but that this is largely
explained by BMI, rather than the presence of T2DM per se.
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